Physician profile
Eric L Wohl
NPI 1376703116
$2,019.95
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $713 · 2020: $485 · 2021: $636 · 2022: $185.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $763.41 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $435.37 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $209.59 | 2019-2021 | |
| Pfizer INC. | $185.87 | 2019-2021 | |
| Boston Scientific Corporation | $123.14 | 2021 | |
| Allergan, INC. | $55.98 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.86 | 2019 | |
| Abbott Laboratories | $41.36 | 2021 | |
| Lilly USA, LLC | $29.49 | 2019-2021 | |
| Cranial Technologies, INC | $26.85 | 2021-2022 | |
| Galderma Laboratories, L.P. | $20.99 | 2021 | |
| Astellas Pharma US INC | $19.38 | 2019 | |
| Glaxosmithkline, LLC. | $16.75 | 2022 | |
| Ibsa Pharma INC. | $15.87 | 2022 | |
| Sanofi Pasteur INC. | $13.66 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $12.38 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Wohl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.